GO
Loading...

Enter multiple symbols separated by commas

Glaxo Wins FDA Approval for Allergy Spray

GlaxoSmithKline won U.S. approval for its Veramyst nasal spray to relieve seasonal and perennial allergies, a U.S. Food and Drug Administration spokeswoman said on Friday.

The drug is approved for use in adults and children two years of age and older, according to Kimberly Rawlings of the FDA.

Analysts have projected peak sales of up to $1 billion a year for the allergy treatment, which is chemically known as fluticasone furoate.

Contact U.S. News

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    Please choose a subscription

    Please enter a valid email address
    To learn more about how we use your information,
    please read our Privacy Policy.

Don't Miss

  • Ferrari 488 Spider

    Ferrari's new 488 Spider will have a V-8 turbo engine and a retractable hard-top roof that lowers in just 14 seconds.

  • Members of the New Horizons science team react to seeing the spacecraft's last and sharpest image of Pluto before closest approach later in the day at the Johns Hopkins University Applied Physics Laboratory (APL) in Laurel, Maryland July 14, 2015.More than nine years after its launch, a U.S. spacecraft sailed past Pluto on Tuesday, capping a 3 billion mile (4.88 billion km) journey to the solar system's farthest reaches, NASA said.

    The New Horizons Pluto flyby mission set records for NASA's social media and web metrics——but why do we care so much?

  • Thomas Lee

    This year's flat market is reminiscent of 1904, says Thomas Lee of Fundstrat Global Advisors in an interview with Amanda Drury.

U.S. Video

  • Investors observe the stock market at a stock exchange hall in Fuyang, Anhui province of China.

    Discussing oil's rally Tuesday, and the Chinese stock market, with Wayne Cooperman, Cobalt Capital Management, and Leon Cooperman, Omega Advisors Chairman & CEO.

  • Two views on Twitter

    Twitter says its monthly active users were 316 million in the recent quarter. Ross Gerber, Gerber Kawasaki CEO, and Max Wolff, Manhattan Venture Partners, share their view of the company.

  • Leon Cooperman: Allergan trying to move up

    Discussing the big run in Allergan, with Wayne Cooperman, Cobalt Capital Management, and Leon Cooperman, Omega Advisors Chairman & CEO.